REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

Javier Martín‐Broto, Virginia Martínez-Marín, Nadia Hindi et al.|Molecular Cancer|2023

Cited by 27